Click for best price
Viral Vectors NonViral Vectors Gene Therapy Manufacturing Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing. This report contains market size and forecasts of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing in global, including the following market information:
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
AAV Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing include BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, Richter-Helm and FUJIFILM Diosynth Biotechnologies, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Segment Percentages, by Type, 2022 (%)
AAV
Adenoviral
Lentiviral
Retroviral
Plasmid DNA
Other Vectors
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Segment Percentages, by Application, 2022 (%)
Cancers
Inherited Disorders
Viral Infections
Others
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Thermo Fisher Scientific (Brammer Bio)
VGXI
PlasmidFactory
bluebird bio
Novasep
Spark Therapeutics
Vigene Biosciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing, market overview.
Chapter 2: Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing market size in revenue.
Chapter 3: Detailed analysis of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
119 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Overall Market Size
2.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size: 2022 VS 2032
2.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players in Global Market
3.2 Top Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Companies Ranked by Revenue
3.3 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Companies
3.4 Top 3 and Top 5 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players in Global Market
3.6.1 List of Global Tier 1 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Companies
3.6.2 List of Global Tier 2 and Tier 3 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Markets, 2022 & 2032
4.1.2 AAV
4.1.3 Adenoviral
4.1.4 Lentiviral
4.1.5 Retroviral
4.1.6 Plasmid DNA
4.1.7 Other Vectors
4.2 By Type - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue & Forecasts
4.2.1 By Type - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, 2018-2023
4.2.2 By Type - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, 2024-2032
4.2.3 By Type - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2022 & 2032
5.1.2 Cancers
5.1.3 Inherited Disorders
5.1.4 Viral Infections
5.1.5 Others
5.2 By Application - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue & Forecasts
5.2.1 By Application - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, 2018-2023
5.2.2 By Application - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, 2024-2032
5.2.3 By Application - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2022 & 2032
6.2 By Region - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue & Forecasts
6.2.1 By Region - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, 2018-2023
6.2.2 By Region - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, 2024-2032
6.2.3 By Region - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, 2018-2032
6.3.2 US Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2018-2032
6.3.3 Canada Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2018-2032
6.3.4 Mexico Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, 2018-2032
6.4.2 Germany Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2018-2032
6.4.3 France Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2018-2032
6.4.4 U.K. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2018-2032
6.4.5 Italy Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2018-2032
6.4.6 Russia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2018-2032
6.4.7 Nordic Countries Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2018-2032
6.4.8 Benelux Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, 2018-2032
6.5.2 China Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2018-2032
6.5.3 Japan Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2018-2032
6.5.4 South Korea Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2018-2032
6.5.5 Southeast Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2018-2032
6.5.6 India Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, 2018-2032
6.6.2 Brazil Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2018-2032
6.6.3 Argentina Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, 2018-2032
6.7.2 Turkey Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2018-2032
6.7.3 Israel Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2018-2032
6.7.4 Saudi Arabia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2018-2032
6.7.5 UAE Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, 2018-2032
7 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Companies Profiles
7.1 BioReliance
7.1.1 BioReliance Company Summary
7.1.2 BioReliance Business Overview
7.1.3 BioReliance Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
7.1.4 BioReliance Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global Market (2018-2023)
7.1.5 BioReliance Key News & Latest Developments
7.2 Cobra Biologics
7.2.1 Cobra Biologics Company Summary
7.2.2 Cobra Biologics Business Overview
7.2.3 Cobra Biologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
7.2.4 Cobra Biologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global Market (2018-2023)
7.2.5 Cobra Biologics Key News & Latest Developments
7.3 Oxford BioMedica
7.3.1 Oxford BioMedica Company Summary
7.3.2 Oxford BioMedica Business Overview
7.3.3 Oxford BioMedica Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
7.3.4 Oxford BioMedica Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global Market (2018-2023)
7.3.5 Oxford BioMedica Key News & Latest Developments
7.4 UniQure
7.4.1 UniQure Company Summary
7.4.2 UniQure Business Overview
7.4.3 UniQure Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
7.4.4 UniQure Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global Market (2018-2023)
7.4.5 UniQure Key News & Latest Developments
7.5 FinVector
7.5.1 FinVector Company Summary
7.5.2 FinVector Business Overview
7.5.3 FinVector Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
7.5.4 FinVector Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global Market (2018-2023)
7.5.5 FinVector Key News & Latest Developments
7.6 MolMed
7.6.1 MolMed Company Summary
7.6.2 MolMed Business Overview
7.6.3 MolMed Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
7.6.4 MolMed Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global Market (2018-2023)
7.6.5 MolMed Key News & Latest Developments
7.7 MassBiologics
7.7.1 MassBiologics Company Summary
7.7.2 MassBiologics Business Overview
7.7.3 MassBiologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
7.7.4 MassBiologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global Market (2018-2023)
7.7.5 MassBiologics Key News & Latest Developments
7.8 Richter-Helm
7.8.1 Richter-Helm Company Summary
7.8.2 Richter-Helm Business Overview
7.8.3 Richter-Helm Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
7.8.4 Richter-Helm Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global Market (2018-2023)
7.8.5 Richter-Helm Key News & Latest Developments
7.9 FUJIFILM Diosynth Biotechnologies
7.9.1 FUJIFILM Diosynth Biotechnologies Company Summary
7.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
7.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
7.9.4 FUJIFILM Diosynth Biotechnologies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global Market (2018-2023)
7.9.5 FUJIFILM Diosynth Biotechnologies Key News & Latest Developments
7.10 Lonza
7.10.1 Lonza Company Summary
7.10.2 Lonza Business Overview
7.10.3 Lonza Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
7.10.4 Lonza Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global Market (2018-2023)
7.10.5 Lonza Key News & Latest Developments
7.11 Aldevron
7.11.1 Aldevron Company Summary
7.11.2 Aldevron Business Overview
7.11.3 Aldevron Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
7.11.4 Aldevron Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global Market (2018-2023)
7.11.5 Aldevron Key News & Latest Developments
7.12 Eurogentec
7.12.1 Eurogentec Company Summary
7.12.2 Eurogentec Business Overview
7.12.3 Eurogentec Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
7.12.4 Eurogentec Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global Market (2018-2023)
7.12.5 Eurogentec Key News & Latest Developments
7.13 Cell and Gene Therapy Catapult
7.13.1 Cell and Gene Therapy Catapult Company Summary
7.13.2 Cell and Gene Therapy Catapult Business Overview
7.13.3 Cell and Gene Therapy Catapult Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
7.13.4 Cell and Gene Therapy Catapult Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global Market (2018-2023)
7.13.5 Cell and Gene Therapy Catapult Key News & Latest Developments
7.14 Biovian
7.14.1 Biovian Company Summary
7.14.2 Biovian Business Overview
7.14.3 Biovian Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
7.14.4 Biovian Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global Market (2018-2023)
7.14.5 Biovian Key News & Latest Developments
7.15 Thermo Fisher Scientific (Brammer Bio)
7.15.1 Thermo Fisher Scientific (Brammer Bio) Company Summary
7.15.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
7.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
7.15.4 Thermo Fisher Scientific (Brammer Bio) Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global Market (2018-2023)
7.15.5 Thermo Fisher Scientific (Brammer Bio) Key News & Latest Developments
7.16 VGXI
7.16.1 VGXI Company Summary
7.16.2 VGXI Business Overview
7.16.3 VGXI Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
7.16.4 VGXI Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global Market (2018-2023)
7.16.5 VGXI Key News & Latest Developments
7.17 PlasmidFactory
7.17.1 PlasmidFactory Company Summary
7.17.2 PlasmidFactory Business Overview
7.17.3 PlasmidFactory Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
7.17.4 PlasmidFactory Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global Market (2018-2023)
7.17.5 PlasmidFactory Key News & Latest Developments
7.18 bluebird bio
7.18.1 bluebird bio Company Summary
7.18.2 bluebird bio Business Overview
7.18.3 bluebird bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
7.18.4 bluebird bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global Market (2018-2023)
7.18.5 bluebird bio Key News & Latest Developments
7.19 Novasep
7.19.1 Novasep Company Summary
7.19.2 Novasep Business Overview
7.19.3 Novasep Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
7.19.4 Novasep Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global Market (2018-2023)
7.19.5 Novasep Key News & Latest Developments
7.20 Spark Therapeutics
7.20.1 Spark Therapeutics Company Summary
7.20.2 Spark Therapeutics Business Overview
7.20.3 Spark Therapeutics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
7.20.4 Spark Therapeutics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global Market (2018-2023)
7.20.5 Spark Therapeutics Key News & Latest Developments
7.21 Vigene Biosciences
7.21.1 Vigene Biosciences Company Summary
7.21.2 Vigene Biosciences Business Overview
7.21.3 Vigene Biosciences Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Major Product Offerings
7.21.4 Vigene Biosciences Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global Market (2018-2023)
7.21.5 Vigene Biosciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Opportunities & Trends in Global Market
Table 2. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Drivers in Global Market
Table 3. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Restraints in Global Market
Table 4. Key Players of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing in Global Market
Table 5. Top Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Share by Companies, 2018-2023
Table 8. Global Companies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Type
Table 9. List of Global Tier 1 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2024-2032
Table 30. BioReliance Company Summary
Table 31. BioReliance Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Offerings
Table 32. BioReliance Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 33. BioReliance Key News & Latest Developments
Table 34. Cobra Biologics Company Summary
Table 35. Cobra Biologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Offerings
Table 36. Cobra Biologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 37. Cobra Biologics Key News & Latest Developments
Table 38. Oxford BioMedica Company Summary
Table 39. Oxford BioMedica Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Offerings
Table 40. Oxford BioMedica Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 41. Oxford BioMedica Key News & Latest Developments
Table 42. UniQure Company Summary
Table 43. UniQure Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Offerings
Table 44. UniQure Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 45. UniQure Key News & Latest Developments
Table 46. FinVector Company Summary
Table 47. FinVector Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Offerings
Table 48. FinVector Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 49. FinVector Key News & Latest Developments
Table 50. MolMed Company Summary
Table 51. MolMed Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Offerings
Table 52. MolMed Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 53. MolMed Key News & Latest Developments
Table 54. MassBiologics Company Summary
Table 55. MassBiologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Offerings
Table 56. MassBiologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 57. MassBiologics Key News & Latest Developments
Table 58. Richter-Helm Company Summary
Table 59. Richter-Helm Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Offerings
Table 60. Richter-Helm Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 61. Richter-Helm Key News & Latest Developments
Table 62. FUJIFILM Diosynth Biotechnologies Company Summary
Table 63. FUJIFILM Diosynth Biotechnologies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Offerings
Table 64. FUJIFILM Diosynth Biotechnologies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 65. FUJIFILM Diosynth Biotechnologies Key News & Latest Developments
Table 66. Lonza Company Summary
Table 67. Lonza Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Offerings
Table 68. Lonza Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 69. Lonza Key News & Latest Developments
Table 70. Aldevron Company Summary
Table 71. Aldevron Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Offerings
Table 72. Aldevron Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 73. Aldevron Key News & Latest Developments
Table 74. Eurogentec Company Summary
Table 75. Eurogentec Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Offerings
Table 76. Eurogentec Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 77. Eurogentec Key News & Latest Developments
Table 78. Cell and Gene Therapy Catapult Company Summary
Table 79. Cell and Gene Therapy Catapult Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Offerings
Table 80. Cell and Gene Therapy Catapult Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 81. Cell and Gene Therapy Catapult Key News & Latest Developments
Table 82. Biovian Company Summary
Table 83. Biovian Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Offerings
Table 84. Biovian Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 85. Biovian Key News & Latest Developments
Table 86. Thermo Fisher Scientific (Brammer Bio) Company Summary
Table 87. Thermo Fisher Scientific (Brammer Bio) Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Offerings
Table 88. Thermo Fisher Scientific (Brammer Bio) Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 89. Thermo Fisher Scientific (Brammer Bio) Key News & Latest Developments
Table 90. VGXI Company Summary
Table 91. VGXI Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Offerings
Table 92. VGXI Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 93. VGXI Key News & Latest Developments
Table 94. PlasmidFactory Company Summary
Table 95. PlasmidFactory Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Offerings
Table 96. PlasmidFactory Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 97. PlasmidFactory Key News & Latest Developments
Table 98. bluebird bio Company Summary
Table 99. bluebird bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Offerings
Table 100. bluebird bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 101. bluebird bio Key News & Latest Developments
Table 102. Novasep Company Summary
Table 103. Novasep Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Offerings
Table 104. Novasep Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 105. Novasep Key News & Latest Developments
Table 106. Spark Therapeutics Company Summary
Table 107. Spark Therapeutics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Offerings
Table 108. Spark Therapeutics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 109. Spark Therapeutics Key News & Latest Developments
Table 110. Vigene Biosciences Company Summary
Table 111. Vigene Biosciences Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Offerings
Table 112. Vigene Biosciences Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 113. Vigene Biosciences Key News & Latest Developments
List of Figures
Figure 1. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Segment by Type in 2022
Figure 2. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Segment by Application in 2022
Figure 3. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in 2022
Figure 8. By Type - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share, 2018-2032
Figure 9. By Application - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share, 2018-2032
Figure 10. By Type - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share, 2018-2032
Figure 12. By Application - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share, 2018-2032
Figure 14. By Region - Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share, 2018-2032
Figure 15. By Country - North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share, 2018-2032
Figure 16. US Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share, 2018-2032
Figure 20. Germany Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 21. France Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share, 2018-2032
Figure 28. China Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 32. India Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share, 2018-2032
Figure 34. Brazil Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share, 2018-2032
Figure 37. Turkey Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 41. BioReliance Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Cobra Biologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Oxford BioMedica Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. UniQure Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. FinVector Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. MolMed Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. MassBiologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Richter-Helm Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. FUJIFILM Diosynth Biotechnologies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Lonza Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Aldevron Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Eurogentec Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Cell and Gene Therapy Catapult Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Biovian Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Thermo Fisher Scientific (Brammer Bio) Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. VGXI Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. PlasmidFactory Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. bluebird bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Novasep Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Spark Therapeutics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Vigene Biosciences Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
